Auxly Cannabis Group

$0.09+0.00+1.07%USD

Auxly Cannabis Group (CBWTF) is a lp cannabis company trading on the OTC. The stock is currently priced at $0.09 with a market capitalization of $111.6M.

Market Cap

$111.6M

Volume

243.0K

Prev Close

$0.08

52W High

$0.14

52W Low

$0.04

P/S Ratio

N/A

Shares Out

1.31B

Revenue

N/A

Gross Margin

0.0%

Cash

N/A

CBWTF Price Chart

Trading Data

Trading Data

Previous Close$0.08
Open$0.08
Day Range$0.04 – $0.14
52-Week Range$0.04 – $0.14
$0.04$0.14
Volume243.0K
Avg Volume243.0K
Market Cap$111.6M
Enterprise Value$111.6M
Shares Outstanding1.31B
P/S Ratio0.00
Revenue Growth YoY0.00%

Valuation Metrics

Valuation Metrics

P/S Ratio (TTM)
0.00Below 5x — attractive
EV / Revenue
vs industry avg ~8x
Gross Margin
0.0%Thin margins
Revenue Growth YoY
0.00%Revenue declining
Cash Runway
Debt-to-Equity

Financial Highlights

View Full Financials

Financial Highlights

R
Revenue TTM$0Trailing twelve months
G
Gross Profit$0Revenue x Margin
%
Gross Margin0.0%Thin profitability
$
Cash & Equivalents$0Available liquidity
D
Total Debt$0Outstanding obligations
N
Net Cash Position$0Cash minus debt

Quarterly Revenue

No quarterly revenue data available

CBWTF Key Takeaways

  • Auxly Cannabis Group (CBWTF) trades at $0.09 with a market cap of $111.6M, ranking #30 among 100 cannabis stocks.
  • Balance sheet shows N/A cash against N/A debt — net debt position.
  • Ranked #9 by market cap in the LP sector. Trades on the OTC exchange.

CBWTF Stock Analysis

Auxly Cannabis Group (CBWTF) is a lp cannabis company listed on the OTC exchange, headquartered in Canada. With a current share price of $0.09 and a market capitalization of $111.6M, CBWTF ranks #30 out of 100 publicly traded cannabis stocks tracked on Cannabismarketcap.

The company's balance sheet shows N/A in cash and equivalents against N/A in total debt, leaving net debt of N/A. Investors looking for a deeper dive can explore CBWTF's full financial statements including quarterly breakdowns and balance sheet history.

CBWTF currently trades within a 52-week range of $0.04 to $0.14. Average daily trading volume stands at 243.0K shares.

Corporate Information

Corporate Information

Company Name
Auxly Cannabis Group
Ticker Symbol
CBWTF
Exchange
OTC
Sector
LPLicensed Producer
Industry
Headquarters
Canada
IPO / List Date
Employees
Website
Market Cap
$111.6M#30 in cannabis
Shares Outstanding
1.31B
Status
Active
Currency
USD

Share Structure

Share Structure

Shares Outstanding
1.31B
Market Cap
$111.6M
Enterprise Value
$111.6M
Float (est.)
1.12B~85% of outstanding
Dilution Rate
Avg Volume
243.0K
Insider Ownership
N/AData pending
Institutional Ownership
N/AData pending
Short Interest
N/AData pending

CBWTF Latest News

Latest News

No recent news available for CBWTF

CBWTF Price History

Investment Snapshot

Investment Snapshot

Programmatic analysis based on available financial data. Not investment advice.

Market PositionNeutral

Ranked #30 of 100 by market cap ($111.6M). Sector median: $32.7M.

Financial HealthNeutral

Gross margin at 0.0%.

GrowthNeutral

Revenue growth at +0.0% YoY. Sector median: +0.0%.

ValuationPositive

P/S ratio of 0.00x vs sector median of 1.83x. Potentially undervalued.

Cannabis Industry Context

Cannabis Industry Overview

Canada became the first G7 nation to legalize recreational cannabis with the passage of the Cannabis Act (Bill C-45) in October 2018, establishing a federally regulated market that licensed producers (LPs) operate within. The Canadian LP landscape is characterized by federal oversight from Health Canada, provincial distribution models that vary by jurisdiction, and intense price compression driven by oversupply and illicit market competition. Many LPs have pivoted toward international expansion as a growth vector, pursuing EU-GMP certification to export medical cannabis to Germany, Poland, the Czech Republic, and other European markets. The European Union represents a significant long-term opportunity, with Germany in particular moving toward a regulated adult-use framework. LPs benefit from listing eligibility on major North American exchanges such as the TSX and Nasdaq, giving them access to institutional capital that remains largely unavailable to US-touching plant operators. However, the Canadian domestic market remains challenging, and investors closely track LPs' paths to sustained profitability, market share within premium product categories, and execution on international distribution.

Auxly Cannabis Group in the Licensed Producer (LP) Landscape

Auxly Cannabis Group (CBWTF) currently ranks #9 out of 25 publicly traded licensed producer (lp) companies by market capitalization, with a market cap of $111.6M. Revenue data is not currently available for this company. The licensed producer (lp) sector comprises 25 tracked companies, reflecting the broad competitive landscape within this segment of the cannabis industry.

The top companies in the licensed producer (lp) sector by market capitalization are Cronos Group (CRON) at $947.6M, Tilray Brands (TLRY) at $802.7M, and SNDL Inc (SNDL) at $388.8M. Auxly Cannabis Group competes within this group for market share, investor attention, and operational scale as the sector continues to mature.

Key Metrics at a Glance

Market Cap$111.6MSector median: $36.1M
Revenue (TTM)N/ASector median: $265.9M
Gross MarginN/ASector median: +0.33%
P/S RatioN/ASector median: 1.3x

Regulatory & Risk Considerations

All cannabis investors should be aware that federal legalization status in the United States remains uncertain. While cannabis is legal for medical use in the majority of US states and for adult use in a growing number of jurisdictions, it remains classified as a Schedule I controlled substance at the federal level. This creates material legal, financial, and operational risks across the industry. Canadian licensed producers like Auxly Cannabis Group operate under a comprehensive federal framework administered by Health Canada, which provides regulatory clarity but also imposes strict requirements around facility licensing, product testing, packaging standardization, and marketing restrictions. While LPs benefit from legitimate banking relationships and major exchange listings, the Canadian market itself faces challenges including persistent illicit market competition, provincial distribution bottlenecks, and retail store rollout timelines that have varied dramatically by province.

For LPs with international operations, the regulatory landscape becomes significantly more complex. Each export destination maintains its own import licensing requirements, product specifications, and quality certifications — most notably EU-GMP certification for European markets. Currency exchange risk, cross-border shipping logistics, and evolving international regulations add layers of operational complexity. LPs must also be mindful of Canadian regulations that restrict certain marketing activities and promotional claims, limiting brand-building opportunities even as the market matures.

CBWTF Key Takeaways

  • Auxly Cannabis Group has a market cap of $111.6M, making it a small-cap cannabis company listed on the OTC.
  • Trailing twelve-month revenue is $0 with year-over-year growth of 0.0%. Declining revenue is a concern that warrants attention.
  • The company's gross margin stands at 0.0%. Low or negative margins raise questions about pricing power and cost structure.
  • Auxly Cannabis Group holds $0 in cash against $0 in debt, resulting in a net debt position of $0 and an estimated 0.0 months of cash runway.
  • The stock trades at a P/S ratio of 0.00x and EV/Revenue of 0.00x. Relatively low multiples could indicate an undervalued opportunity.
  • At $0.09, the stock trades at 45% of its 52-week range ($0.04 – $0.14). The stock is trading mid-range, offering a balanced risk-reward profile.
  • The annual share dilution rate is 0.0%. Low dilution is a positive sign of disciplined capital management.

Auxly Cannabis Group Stock Analysis

Auxly Cannabis Group (OTC: CBWTF) is a licensed producer (lp) company currently trading at $0.09 per share with a market capitalization of $111.6M. The stock gained +1.07% in the most recent trading session on volume of 243.0K shares. Auxly Cannabis Group is headquartered in Canada and employs approximately 0 people. As a participant in the licensed producer (lp) segment, the company operates within one of the most dynamic and rapidly evolving sectors of the North American economy.

On the revenue front, Auxly Cannabis Group generated $0 in trailing twelve-month (TTM) revenue, reflecting year-over-year growth of 0.0%. This growth rate is trailing the LP sector average of 0.0%. Auxly Cannabis Group currently operates with a negative gross margin of 0.0%, meaning the company's cost of goods sold exceeds its revenue. This is a significant concern and suggests the business needs to either increase prices, reduce production costs, or achieve greater economies of scale. Revenue trends in the cannabis industry are closely watched by analysts, as the sector continues to navigate pricing compression, oversupply dynamics in certain markets, and the ongoing burden of IRS Section 280E, which prevents cannabis businesses from deducting ordinary business expenses at the federal level.

From a valuation perspective, Auxly Cannabis Group trades at a price-to-sales (P/S) ratio of 0.00x, which is below the sector median of 0.00x, which could indicate the stock is undervalued relative to peers or that the market has concerns about the company's growth trajectory. The enterprise value-to-revenue (EV/Revenue) multiple stands at 0.00x. Cannabis stock valuations have compressed significantly from their 2021 highs, and current multiples reflect a more mature market environment where investors demand clear paths to profitability. For context, the broader LP sector contains 25 publicly traded companies tracked by CannaCap, and Auxly Cannabis Group's valuation should be considered within the context of its specific growth profile and competitive positioning.

Auxly Cannabis Group carries net debt of $0, with $0 in total debt against $0 in cash and equivalents. At the current pace, the company has an estimated 0.0 months of cash remaining, making capital management a critical near-term priority. Access to capital remains a persistent challenge for cannabis companies, particularly plant-touching operators that are excluded from traditional banking services and institutional lending. Many cannabis companies have turned to sale-leaseback transactions, private placements, and at-the-market (ATM) equity offerings to fund operations. Auxly Cannabis Group's balance sheet should be evaluated with these industry-specific constraints in mind.

Key risk factors for Auxly Cannabis Group investors include the ongoing federal prohibition of cannabis in the United States, which creates regulatory uncertainty and limits access to capital markets. The company has maintained relatively low share dilution at 0.0% annually, which is favorable for existing shareholders and indicates disciplined capital management. The stock currently trades at $0.09, which is 45% of the way between its 52-week low of $0.04 and its 52-week high of $0.14. Additional industry-wide risks include potential state-level regulatory changes, evolving consumer preferences, price compression from increased competition, and the impact of illicit market activity on legal operators. The Section 280E tax burden continues to weigh on cannabis company profitability, and any federal rescheduling or descheduling of cannabis would be a significant catalyst for the entire sector.

The cannabis industry is at a pivotal juncture, with potential federal reform, state-level market expansion, and increasing institutional interest all shaping the investment landscape. Auxly Cannabis Group, with its $111.6M market cap and $0 revenue base, is positioned as a smaller player in the licensed producer (lp) space. Investors considering CBWTF should weigh the company's financial metrics against the broader opportunity set within the cannabis sector, which includes 100 publicly traded companies tracked on CannaCap with a combined market capitalization measured in the tens of billions of dollars.

CBWTF Price Performance

Auxly Cannabis Group (CBWTF) currently trades at $0.09, which places the stock at approximately 45% of its 52-week trading range. Over the past twelve months, CBWTF has traded as high as $0.14 and as low as $0.04, representing a 207.0% spread between the yearly high and low. The current price sits 37.4% below the 52-week high and 92.3% above the 52-week low. This range provides important context for understanding the stock's recent volatility and where current levels fall within the broader price history.

In the most recent trading session, CBWTF rose +1.07% from a previous close of $0.08 to $0.09, on volume of 243.0K shares. This positive session is within the range of normal daily fluctuations for cannabis stocks, which tend to exhibit higher volatility than the broader equity market. The stock has 1,313,000,000 shares outstanding, giving it a fully diluted market capitalization that investors should factor into their analysis alongside the current $111.6M market cap figure.

Cannabis stocks have historically exhibited significant price volatility driven by regulatory developments, earnings surprises, and shifts in market sentiment toward the sector. CBWTF is trading in the middle of its 52-week range, which suggests the stock has room to move in either direction based on fundamental catalysts. Historical price levels should be considered alongside fundamental data — including revenue trends, margin improvement, and balance sheet health — to form a complete investment thesis.

How to Invest in Auxly Cannabis Group

Auxly Cannabis Group (CBWTF) is listed on the OTC (Over-The-Counter) Markets, which is a decentralized marketplace for securities not listed on major exchanges. OTC stocks can be traded through most full-service brokerages, though some discount brokers may charge additional fees or restrict access to certain OTC tiers. Investors should be aware that OTC-traded stocks typically have lower liquidity and wider bid-ask spreads compared to exchange-listed securities. To purchase shares of CBWTF, you will need a brokerage account that supports trading on the OTC. The stock currently trades at $0.09 per share with an average daily volume of 243.0K shares, which provides adequate liquidity for most retail investors. When placing an order, consider using limit orders rather than market orders to control your entry price, especially given the wider spreads typical of OTC-traded securities.

Investors evaluating Auxly Cannabis Group should closely monitor several key financial metrics. The company's trailing twelve-month revenue of $0 and year-over-year revenue growth of 0.0% provide insight into top-line momentum. The gross margin of 0.0% indicates how efficiently the company converts revenue into gross profit. On the balance sheet, Auxly Cannabis Group holds $0 in cash against $0 in total debt, giving it approximately 0.0 months of operating runway. The price-to-sales ratio of 0.00x and enterprise value-to-revenue of 0.00x help contextualize the stock's valuation relative to its revenue generation. Watch quarterly earnings reports for trends in these metrics, as well as any changes to guidance or strategic direction.

When comparing Auxly Cannabis Group to other cannabis investments, consider the company's sector (Licensed Producer (LP)), geographic focus (Canada), and stage of growth. As a small-cap cannabis company, Auxly Cannabis Group carries higher risk but may offer greater upside potential if the company executes on its growth strategy. The cannabis sector is highly fragmented, and understanding where a company fits within the broader competitive landscape — including its market share, geographic footprint, and product differentiation — is essential for making informed investment decisions.

Important risk disclosure: Cannabis stocks carry unique risks beyond those of typical equity investments. Federal illegality in the United States creates regulatory, banking, and tax challenges (particularly Section 280E). State-by-state legalization creates a patchwork of market opportunities and compliance requirements. Cannabis companies frequently issue additional shares to fund operations, which dilutes existing shareholders — Auxly Cannabis Group's current dilution rate is 0.0% annually. Past performance is not indicative of future results, and investors should only allocate capital they can afford to lose. This content is for informational purposes only and does not constitute investment advice. Always conduct your own due diligence and consider consulting a financial advisor before investing in cannabis stocks.

Compare CBWTF With Peers

Peer Comparison

CompanyPriceChange %Mkt CapRevenueMarginP/S
CBWTF$0.09+1.07%$111.6M$00.0%0.00
CRON$2.50+0.81%$947.6M$146.6M0.4%6.46
TLRY$6.89-1.57%$802.7M$837.3M0.3%0.96
SNDL$1.51-5.03%$388.8M$00.0%0.00
CGC$1.02-2.86%$385.4M$278.4M0.3%1.38
VFF$2.87-6.51%$331.5M$253.3M0.4%1.31

Related LP Stocks

Frequently Asked Questions

What is Auxly Cannabis Group's (CBWTF) stock price today?

Auxly Cannabis Group (CBWTF) stock is currently trading at $0.09 per share on the OTC exchange. This represents a daily gain of +1.07% ($0.00) from the previous closing price of $0.08. Over the past 52 weeks, CBWTF has traded between a low of $0.04 and a high of $0.14, placing the current price at approximately -37% from its annual high. The stock has a market capitalization of $111.6M, making it a notable cannabis companies tracked by Cannabismarketcap. Auxly Cannabis Group operates in the LP sector, serving the broader cannabis industry.

What is Auxly Cannabis Group's market capitalization?

Auxly Cannabis Group (CBWTF) has a current market capitalization of $111.6M, calculated by multiplying its 1.31B shares outstanding by the current stock price of $0.09. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places Auxly Cannabis Group among the mid-cap cannabis companies tracked on Cannabismarketcap. For context, the enterprise value (market cap plus debt minus cash) stands at $111.6M, which accounts for the company's balance sheet structure. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.

Is Auxly Cannabis Group profitable?

Auxly Cannabis Group (CBWTF) currently reports a gross margin of 0.0%, which means the company loses 0.0 cents of every revenue dollar after direct costs of goods sold. Profitability is a critical factor in the cannabis industry, where many companies are still investing heavily in growth and regulatory compliance. Investors should review the full income statement, cash flow trends, and operating expense breakdown on Cannabismarketcap for a complete picture of Auxly Cannabis Group's financial health.

What are Auxly Cannabis Group's key financial metrics?

Auxly Cannabis Group (CBWTF) reports several important financial metrics that investors track closely. The company has a market capitalization of $111.6M, trailing twelve month revenue of N/A, and a gross margin of 0.0%. On the balance sheet, Auxly Cannabis Group holds $0 in cash and equivalents against $0 in total debt, resulting in a debt-to-market-cap ratio of 0.00x. With 1.31B shares outstanding, investors should consider both the fundamental financial performance and share structure when evaluating CBWTF.

What exchange is CBWTF listed on?

Auxly Cannabis Group trades under the ticker symbol CBWTF on the OTC exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts, though some brokers may charge additional fees for OTC-listed securities. The stock sees average daily trading volume of approximately 243.0K shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.

What sector is Auxly Cannabis Group in?

Auxly Cannabis Group is classified as a LP company within the cannabis industry, meaning it is a licensed producer of cannabis, typically operating under a national framework for cultivation and distribution. The LP sector is a key segment of the cannabis market, and investors often compare companies within the same sector to identify relative outperformers. You can compare CBWTF with other LP stocks on Cannabismarketcap's sector page to see how it ranks on metrics like market cap, revenue, and margins.

What is Auxly Cannabis Group's gross margin?

Auxly Cannabis Group (CBWTF) has a gross margin of 0.0%, which represents the percentage of revenue the company retains after paying for the direct cost of goods sold. Gross margin is a critical profitability indicator in the cannabis industry, where companies face unique cost pressures from regulatory compliance, testing requirements, and the tax burden of IRC Section 280E (which prevents cannabis companies from deducting standard business expenses). A negative gross margin like Auxly Cannabis Group's suggests the company is facing challenges in cost management or pricing.

How does CBWTF compare to other cannabis stocks?

You can compare Auxly Cannabis Group (CBWTF) side-by-side with any cannabis stock on Cannabismarketcap using the dedicated comparison tool. Key comparison metrics include market cap ($111.6M), trailing twelve month revenue (N/A), gross margin (0.0%), and price-to-sales ratio (N/A). Auxly Cannabis Group sits in the LP sector, so the most relevant peer comparisons would be against other LP companies, though cross-sector comparisons can also reveal interesting insights about relative valuation. Visit the rankings page to see where CBWTF stands across all cannabis companies on metrics like revenue growth (0.00% YoY), cash position ($0), and employee count (N/A).

What is CBWTF's 52-week trading range?

Auxly Cannabis Group (CBWTF) has traded between a 52-week low of $0.04 and a 52-week high of $0.14, with the current price of $0.09 sitting approximately -37% from the annual high. This range represents a spread of $0.09 (207% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.

How does Auxly Cannabis Group's valuation compare to cannabis industry peers?

Auxly Cannabis Group (CBWTF) is valued at a market capitalization of $111.6M, and an enterprise value of $111.6M. In the cannabis industry, valuations can vary significantly depending on sector (MSO, LP, Ancillary, etc.), growth rate, and path to profitability. Auxly Cannabis Group's current revenue trajectory of 0.00% YoY may result in a lower valuation relative to faster-growing peers. Investors can use the Cannabismarketcap rankings and comparison tools to benchmark CBWTF against specific competitors on valuation multiples, growth rates, and profitability.

What is Auxly Cannabis Group's enterprise value?

Auxly Cannabis Group (CBWTF) has an estimated enterprise value (EV) of $111.6M, which is calculated by taking the market capitalization of $111.6M, adding total debt of $0, and subtracting cash and equivalents of $0. Enterprise value is widely considered a more comprehensive measure of a company's total value than market cap alone because it accounts for the capital structure, including debt obligations and available liquidity. For cannabis companies in particular, where balance sheet health varies dramatically, enterprise value provides a more accurate picture of acquisition cost and relative valuation.

Is Auxly Cannabis Group stock overvalued or undervalued?

Determining whether Auxly Cannabis Group (CBWTF) is overvalued or undervalued requires analyzing multiple valuation metrics in context. The stock is currently trading at $0.09, which is -37% from its 52-week high of $0.14, with a gross margin of 0.0%. Investors should consider the company's enterprise value of $111.6M, its cash position of $0, and the broader cannabis industry outlook when forming a valuation opinion. Cannabismarketcap provides all the data needed for a thorough analysis, but this information should not be considered investment advice.

What are the risks of investing in Auxly Cannabis Group?

Investing in Auxly Cannabis Group (CBWTF) carries several risks that investors should carefully consider. First, the cannabis industry remains federally illegal in the United States, creating regulatory uncertainty that can impact stock prices, banking access, and tax obligations (notably IRC Section 280E). Second, Auxly Cannabis Group's balance sheet shows $0 in total debt against $0 in cash, which investors should monitor for dilution risk or liquidity concerns. Additionally, the stock has shown a 52-week range of $0.04 to $0.14, reflecting meaningful price volatility. As with all cannabis stocks, investors face risks from changing state regulations, competitive pressures, and the evolving legal landscape. This information is for educational purposes only and is not investment advice.

What is Auxly Cannabis Group's cash position and debt level?

Auxly Cannabis Group (CBWTF) holds $0 in cash and equivalents on its balance sheet, set against $0 in total debt. This gives the company a net debt position of $0. Balance sheet strength is especially important in the cannabis industry, where companies often face limited access to traditional banking and capital markets. Investors should track these metrics over time on Cannabismarketcap to identify trends in cash consumption and debt management.

How many shares outstanding does Auxly Cannabis Group have?

Auxly Cannabis Group (CBWTF) currently has 1.31B shares outstanding, which when multiplied by the current stock price of $0.09 gives the company its market capitalization of $111.6M. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.

Does Auxly Cannabis Group pay a dividend?

Most cannabis companies, including Auxly Cannabis Group (CBWTF), do not currently pay dividends. The cannabis industry is still in a growth phase, and companies typically reinvest available capital into expanding operations, securing new licenses, building out retail and cultivation infrastructure, and navigating complex regulatory requirements. Additionally, the IRC Section 280E tax burden significantly reduces the free cash flow available for shareholder distributions. Investors in cannabis stocks should generally expect returns to come from capital appreciation rather than dividend income. If Auxly Cannabis Group initiates a dividend in the future, it would be reported in their SEC filings and reflected on Cannabismarketcap.

How can I research Auxly Cannabis Group stock before investing?

To research Auxly Cannabis Group (CBWTF) before investing, start with the company overview on Cannabismarketcap, which provides current price ($0.09), market cap ($111.6M), and key financial metrics. Next, review the full financial statements page for quarterly revenue trends, margins, and balance sheet details. Check the analyst ratings page for Wall Street consensus and price targets, and the technical analysis page for chart patterns and momentum indicators. Compare CBWTF against sector peers using the comparison tool to understand relative valuation. Review recent news coverage for regulatory developments or corporate events. Finally, read the investment analysis page for a comprehensive deep-dive. Cannabis investing carries unique risks including federal illegality, regulatory uncertainty, and limited banking access — always conduct thorough due diligence before making any investment decision.

What does Auxly Cannabis Group's market cap of $111.6M mean?

Auxly Cannabis Group's market capitalization of $111.6M represents the total market value of all its outstanding shares (1.31B shares multiplied by the current stock price of $0.09). Market cap is the primary measure investors use to classify companies by size: mid-cap companies ($100M–$1B) like Auxly Cannabis Group offer a balance between growth potential and stability. In the cannabis sector, market cap is especially important because it determines index weighting, institutional investment eligibility, and often correlates with the company's operational scale and geographic reach. Auxly Cannabis Group currently ranks # among cannabis stocks tracked on Cannabismarketcap.

What regulatory risks does Auxly Cannabis Group face?

Auxly Cannabis Group (CBWTF), like all cannabis companies, faces significant regulatory risks that investors should understand. At the federal level, cannabis remains a Schedule I controlled substance in the United States, which restricts banking access, prevents standard business expense deductions under IRC Section 280E, and creates legal uncertainty. As a licensed producer, Auxly Cannabis Group operates under national cannabis frameworks that can change with new government policy, affecting production quotas, export capabilities, and market access. Potential catalysts include federal rescheduling (which could ease 280E burdens), the SAFE Banking Act (which would improve banking access), and individual state legalization events. Conversely, regulatory setbacks such as license moratoriums, increased enforcement, or unfavorable tax policy changes pose downside risks. Investors should monitor legislative developments closely using Cannabismarketcap's news and legalization tracker.

Auxly Cannabis Group (CBWTF) is a lp cannabis company listed on the OTC exchange, headquartered in Canada. With a market capitalization of $111.6M, Auxly Cannabis Group ranks #30 among all 100 publicly traded cannabis companies tracked on Cannabismarketcap. The stock is currently trading at $0.09, representing a gain of +1.07% today on volume of 243.0K shares. For real-time price tracking and analysis, see our CBWTF news page and financial statements.

Investors researching CBWTF can access detailed financial data including revenue, margins, and balance sheet metrics. For broader market context, explore the LP sector overview, browse all OTC-listed cannabis stocks, or view the market cap rankings, revenue rankings, and P/S ratio rankings. Use the stock screener to filter cannabis stocks by any metric.

Compare Auxly Cannabis Group head-to-head with other cannabis stocks using our comparison tool. Popular comparisons include CBWTF vs CRON, CBWTF vs TLRY, and CBWTF vs SNDL. Track CBWTF alongside the entire cannabis market with Cannabismarketcap's comprehensive gross margin rankings, cash position rankings, and valuation rankings.

New to cannabis investing? Learn about the industry with our guides on cannabis stock basics, how to evaluate cannabis stocks, and industry overview. Cannabismarketcap tracks every publicly traded cannabis company with real-time pricing, detailed financials, and programmatic analysis to help investors make informed decisions.

Embed CBWTF Widget

Add the CBWTF price widget to your website or blog:

<iframe src="https://cannabismarketcap.io/embed/cbwtf" width="320" height="180" frameborder="0" style="border-radius:8px;border:1px solid #415a77"></iframe>

Data updates every 2 minutes. Free for non-commercial use.

Disclaimer

The information on this page is provided for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Cannabismarketcap is not a registered broker-dealer or investment advisor. All data, including stock prices, market capitalizations, financial metrics, and analysis for Auxly Cannabis Group (CBWTF), is provided “as is” without warranty of any kind. Past performance does not guarantee future results. Cannabis stocks are highly volatile and carry significant risk, including the potential for total loss of investment. Marijuana remains illegal under federal law in the United States. Always conduct your own due diligence and consult a qualified financial advisor before making investment decisions. Data may be delayed or inaccurate. See our terms of service and privacy policy for more information.